The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
Open accessAbstract
Bacterial type II CRISPR-Cas9 systems have been widely adapted for RNA-guided genome editing and transcription regulation in eukaryotic cells, yet their in vivo target specificity is poorly understood. Here we mapped genome-wide binding sites of a catalytically inactive Cas9 (dCas9) from Streptococcus pyogenes loaded with single guide RNAs (sgRNAs) in mouse embryonic stem cells (mESCs). Each of the four sgRNAs we tested targets dCas9 to between tens and thousands of genomic sites, frequently characterized by a 5-nucleotide seed region in the sgRNA and an NGG protospacer adjacent motif (PAM). Chromatin inaccessibility decreases dCas9 binding to other sites with matching seed sequences; thus 70% of off-target sites are associated with genes. Targeted sequencing of 295 dCas9 binding sites in mESCs transfected with catalytically active Cas9 identified only one site mutated above background levels. We propose a two-state model for Cas9 binding and cleavage, in which a seed match triggers binding but extensive pairing with target DNA is required for cleavage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Delivery methods improvement | Application in cell culture [89–94] | Viral transduction | May cause accumulation of off-target mutations |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [93]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Delivery methods improvement | Application in cell culture [89–94] | Plasmid transfection | May cause accumulation of off-target mutations |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [93]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“| Delivery methods improvement | Application in cell culture [89–94] | RNP electroporation: Rapid transfection and turnover | Eliminate off-target effects |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [93]
Experimental — accuracy not yet measuredIn the citing paper
“A key feature of our system is the transient expression of the nuclease Cas9, through delivery of mRNA. This allowed for sufficient exposure to the nuclease for gene repair and reduced concerns associated with long-term nuclease exposure34.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [34]
In the citing paper
“And moreover, DNA binding and cleavage by Cas9 are in some cases uncoupled, that is, Cas9 can bind to but not cleave DNA sequences that are partially complementary to sgRNA 49 and exert epigenomic regulatory effects, 43 44 which is unpredictable by silicon methods relying on base pairing.”
From CRISPR-Cas9: a new and promising player in gene therapy (2015) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationWebLogo: A Sequence Logo Generator: Figure 1Preprint
Crooks, G. E., Hon, G. C., Chandonia, J., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,418
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citationRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 944
Applications of and considerations for using CRISPR–Cas9-mediated gene conversion systems in rodents
Grunwald, H. A., Weitzel, A. J., & Cooper, K. L. (2021) · Nature Protocols · doi:10.1038/s41596-021-00646-7 · Cited by 12
A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
Porter, S. N., Levine, R. M., & Pruett‐Miller, S. M. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180022 · Cited by 18
Editing DNA methylation in vivo
Pan, R. J., Ren, J., Chen, X., Flores, L. F., Gonzalez, R. V. L., Adonnino, A. A., Lofts, B. R., Waldo, J. J., Halmai, J. A. N. M., Devinsky, O., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67222-5 · Cited by 11
Chronic In Vivo CRISPR-Cas Genome Editing: Challenges, Long-Term Safety, and Outlook
Bao, C., Channell, C. I., Tseng, Y.-H., Bailey, J., Sbaiti, N., Demirkol, A., & Tsang, S. H. (2026) · Cells · doi:10.3390/cells15020156 · Cited by 14
Tandem repeat knockout utilizing the CRISPR/Cas9 system in human cells
Lv, Q., Lai, L., Yuan, L., Song, Y., Sui, T., & Li, Z. (2016) · Gene · doi:10.1016/j.gene.2016.02.013 · Cited by 11
Patel, A., Iannello, G., Diaz, A. G., Sirabella, D., Thaker, V., & Corneo, B. (2022) · Current Protocols · doi:10.1002/cpz1.519 · Cited by 11
Yang, Y., Zhang, C., Song, Y., Li, Y., Li, P., Huang, M., Meng, F., & Zhang, M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac742 · Cited by 11
Fujii, H., & Fujita, T. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921802 · Cited by 11
CRISPRing protozoan parasites to better understand the biology of diseases
Kirti, A., Sharma, M. D., Rani, K., & Bansal, A. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.004 · Cited by 13
Yang, Z., Zhang, Z., Li, J., Chen, W., & Liu, C. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae066 · Cited by 11
Efficient generation of FVII gene knockout mice using CRISPR/Cas9 nuclease and truncated guided RNAs
An, L., Hu, Y., Chang, S., Zhu, X., Ling, P., Zhang, F., Liu, J., Liu, Y., Chen, Y., Yang, L., et al. (2016) · Scientific Reports · doi:10.1038/srep25199 · Cited by 11
CRISPR/Cas9 as a tool to dissect cancer mutations
Sayed, S., Paszkowski‐Rogacz, M., Schmitt, L. T., & Buchholz, F. (2019) · Methods · doi:10.1016/j.ymeth.2019.05.007 · Cited by 11
CRISPR/Cas-based Human T cell Engineering: Basic Research and Clinical Application
Bernard, B. E., Landmann, E., Jeker, L. T., & Schumann, K. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.03.005 · Cited by 12
CRISPR-Cas type II-based Synthetic Biology applications in eukaryotic cells
Marchisio, M. A., & Huang, Z. (2017) · RNA Biology · doi:10.1080/15476286.2017.1282024 · Cited by 11
Genome Editing in Human Pluripotent Stem CellsPreprint
Smith, C. J., Ye, Z., & Cheng, L. (2016) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top086819 · Cited by 11
Chromatin structure and context-dependent sequence features control prime editing efficiency
Kim, S., Yuan, J. B., Woods, W. S., Newton, D. A., Perez-Pinera, P., & Song, J. S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1222112 · Cited by 12
CRISPR-Based Transcriptional Regulation: Technologies, Applications, and Future Directions
Srinivasa, M. A., & Escobar, M. (2025) · DNA · doi:10.3390/dna5040057 · Cited by 11
Lee, S., Hong, S., Park, J., Koh, Y., Lee, H., Yang, J., Seo, S. W., & Kim, S. J. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05539 · Cited by 11
Dorighi, K. M., Zhu, A., Fortin, J., Lo, J. H.-H., Sudhamsu, J., Wendorff, T. J., Durinck, S., Callow, M. G., Foster, S. A., & Haley, B. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114313 · Cited by 11
Goolab, S., & Scholefield, J. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1464531 · Cited by 10
Unleashing the Potential of CRISPR/Cas9 Genome Editing for Yield-Related Traits in Rice
Thiruppathi, A., Salunkhe, S. R., Ramasamy, S. P., Palaniswamy, R., Rajagopalan, V. R., Rathnasamy, S. A., Senthil, A., Swaminathan, M., Sudha, M., & Raveendran, M. (2024) · Plants · doi:10.3390/plants13212972 · Cited by 15
Unraveling of Central Nervous System Disease Mechanisms Using CRISPR Genome Manipulation
Vesikansa, A. (2018) · Journal of Central Nervous System Disease · doi:10.1177/1179573518787469 · Cited by 10
Development and challenges of using CRISPR-Cas9 system in mammalians
Khambhati, K., Gohil, N., Bhattacharjee, G., & Singh, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818140-9.00007-6 · Cited by 10
Delivery Methods, Resources and Design Tools in CRISPR/Cas
Aslam, M. A., Hammad, M., Ahmad, A., Altenbuchner, J., & Ali, H. (2021) · Springer eBooks · doi:10.1007/978-981-15-7142-8_3 · Cited by 10
Ratner, H. K., & Weiss, D. S. (2021) · RNA Biology · doi:10.1080/15476286.2021.1878335 · Cited by 10
Li, Y., & Zhou, L. (2021) · BioEssays · doi:10.1002/bies.202100086 · Cited by 11
Dynamic observations of CRISPR‐Cas target recognition and cleavage heterogeneities
Zhang, Z., Jeong, H., Zu, D., Zhao, X., Senaratne, P., Filbin, J., Silber, B., Kang, S., Gladstone, A., Lau, M. S., et al. (2022) · Nanophotonics · doi:10.1515/nanoph-2022-0286 · Cited by 10
Puppulin, L., Ishikawa, J., Sumino, A., Marchesi, A. S., Flechsig, H., Umeda, K., Kodera, N., Nishimasu, H., & Shibata, M. (2023) · ACS Nano · doi:10.1021/acsnano.2c10709 · Cited by 10
Nanoparticle-mediated delivery of non-viral gene editing technology to the brain
Williams, L., & Larsen, J. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102547 · Cited by 10
CRISPR/Cas9: The Leading Edge of Genome Editing Technology
Sakuma, T., & Yamamoto, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-55227-7_2 · Cited by 10
Spencer, N. Y., Yan, Z., Cong, L., Zhang, Y., Engelhardt, J. F., & Stanton, R. C. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.11.002 · Cited by 10
CRISPR/Cas9: a breakthrough in generating mouse models for endocrinologists
Markossian, S., & Flamant, F. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0305 · Cited by 11
A surrogate reporter system for multiplexable evaluation of CRISPR/Cas9 in targeted mutagenesis
Zhang, H., Zhou, Y., Wang, Y., Zhao, Y., Qiu, Y., Zhang, X., Yue, D., Zhou, Z. L., & Wei, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-19317-x · Cited by 10
Site-specific integration of rotavirus VP6 gene in rabbit β-casein locus by CRISPR/Cas9 system
Li, H., Li, Z., Xiao, N., Su, X., Zhao, S., Zhang, Y., Cui, K., Liu, Q., & Shi, D. (2019) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-019-00382-z · Cited by 10
Marzec, M., & Hensel, G. (2019) · FEBS Journal · doi:10.1111/febs.15079 · Cited by 10
Emergent challenges for CRISPR: biosafety, biosecurity, patenting, and regulatory issues
Braddick, D., & Ramarohetra, R. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818140-9.00021-0 · Cited by 10
Yang, D., Wu, X., Zhou, Y., Wang, W., & Wang, Z. (2020) · EMBO Reports · doi:10.15252/embr.201949431 · Cited by 11
Choudhary, P., Mushtaq, M., Singh, A. K., Mukhtar, S., Shah, A. A., Mehta, G., & Bakshi, P. (2017) · European Journal of Experimental Biology · doi:10.21767/2248-9215.100020 · Cited by 10
Pantoja‐Angles, A., Ali, Z., & Mahfouz, M. M. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00516 · Cited by 9
Carneiro, P., de Freitas, M. V., & Matte, Ú. D. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262299 · Cited by 9
Chen, X., Perry, S., Fan, Z., Wang, B., Loxterkamp, E., Wang, S., Hu, J., Dickman, D. K., & Han, C. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011438 · Cited by 11
Mao, S., Wu, R., Luo, W., Qin, J., & Chen, A. K. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf192 · Cited by 9
TOPO-seq reveals DNA topology-induced off-target activity by Cas9 and base editors
Duan, M., Gao, P., Zhang, Y.-Z., Hu, Y.-L., Zhou, L., Xu, Z.-C., Qiu, H.-Y., Tong, X., Ji, R.-J., Lei, X.-L., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01867-7 · Cited by 8
Marco, F. D., Sebastian, I. R., Napoleone, A., Molin, A., Riedl, M., Bydlinski, N., Motheramgari, K., Hussein, M. K., Kramer, L., Kelly, T. J., et al. (2025) · Metabolic Engineering · doi:10.1016/j.ymben.2025.08.007 · Cited by 9
Non-coding RNAs in heart failure: epigenetic regulatory mechanisms and therapeutic potential
Ren, Y., Zhao, B., Lv, L., Jingyuan, Y., Nan, X., Bao, L., & Yang, B. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1677797 · Cited by 9
Overcoming functional and translational challenges of cellular immunotherapies for solid tumors
Chen, Y.-C., Chen, K., Levine, B. L., & Shah, K. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.02.002 · Cited by 9
Fujita, T., & Fujii, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023143 · Cited by 9
PINCER: improved CRISPR/Cas9 screening by efficient cleavage at conserved residues
Veeneman, B. A., Gao, Y., Grant, J., Fruhling, D., Ahn, J. H., Bosbach, B., Bienkowska, J. R., Follettie, M. T., Arndt, K. T., Myers, J. S., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa645 · Cited by 11
System-Based Approaches to Delineate the Antiviral Innate Immune Landscape
Krey, K., Babnis, A. W., & Pichlmair, A. (2020) · Viruses · doi:10.3390/v12101196 · Cited by 10
Gene Editing in Dimorphic Fungi Using CRISPR/Cas9
Kujoth, G. C., Sullivan, T. D., & Klein, B. S. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.132 · Cited by 8
Mechanisms of the Specificity of the CRISPR/Cas9 System in Genome Editing
Kulishova, L. M., Vokhtantsev, I. P., Kim, D. V., & Zharkov, D. O. (2023) · Molecular Biology · doi:10.1134/s0026893323020139 · Cited by 10
gRNA Design: How Its Evolution Impacted on CRISPR/Cas9 Systems Refinement
Motoche-Monar, C., Ordoñez, J. E., Chang, O., & Gonzales-Zubiate, F. A. (2023) · Biomolecules · doi:10.3390/biom13121698 · Cited by 12
Emerging Sensing and In Situ Detection Technologies for the Analysis of Extracellular Vesicle miRNAs
Han, J., Wang, C., Zhu, L., & Yang, Y. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300067 · Cited by 9
Precision genetic technologies for cereal functional genomics
Liang, Y., Li, C., Mangrauthia, S. K., & Biswal, A. K. (2023) · Journal of Plant Biochemistry and Biotechnology · doi:10.1007/s13562-023-00862-0 · Cited by 9
CRISPR/Cas9, a universal tool for genomic engineering
Smirnov, A. V., Yunusova, A., Lukyanchikova, V., & Баттулин, Н. Р. (2016) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj16.175 · Cited by 11
Is microfluidics the “assembly line” for CRISPR-Cas9 gene-editing?
Ahmadi, F., Quach, A. B. V., & Shih, S. C. C. (2020) · Biomicrofluidics · doi:10.1063/5.0029846 · Cited by 10
Predicting CRISPR-Cas9 Off-target with Self-supervised Neural Networks
Chen, D., Shu, W., & Peng, S. (2020) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm49941.2020.9313280 · Cited by 9
Single-guide RNAs: rationale and design
Chang, A. Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817876-8.00003-6 · Cited by 9
Immunoblot screening of CRISPR/Cas9-mediated gene knockouts without selection
Estep, J. A., Sternburg, E. L., Sanchez, G. A., & Karginov, F. V. (2016) · BMC Molecular Biology · doi:10.1186/s12867-016-0061-0 · Cited by 9
Therapeutic perspectives for structural and functional abnormalities of cilia
Kim, Y. J., & Kim, J. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03158-6 · Cited by 13
Discovering the Genome-Wide Activity of CRISPR-Cas Nucleases
Tsai, S. Q. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00847 · Cited by 9
Genome-wide CRISPR off-target DNA break detection by the BLISS method
Ballarino, R., Bouwman, B. A. M., & Crosetto, N. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-0687-2_15 · Cited by 8
Recent advances in genome engineering by CRISPR technology
Lee, Y., Oh, Y., & Lee, S. H. (2024) · BMB Reports · doi:10.5483/bmbrep.2023-0157 · Cited by 10
Harnessing CRISPR potential for intervertebral disc regeneration strategies
Milheiro, C., Moura, M. L., Amendola, M., Barbosa, M. A., & Caldeira, J. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1562412 · Cited by 10
A cleavage-based surrogate reporter for the evaluation of CRISPR–Cas9 cleavage efficiency
Jung, S. B., Lee, C. Y., Lee, K., Heo, K., & Choi, S. H. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab467 · Cited by 8
Challenges and Future Prospects of CRISPR Technology
Khan, Z., Khan, S. H., & Ahmad, A. (2021) · Springer eBooks · doi:10.1007/978-981-16-6305-5_10 · Cited by 9
Presnell, K. V., Melhem, O., Morse, N. J., & Alper, H. S. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00327 · Cited by 8
Dong, Y., Cai, X., Wu, Y., Liu, Y., Deng, L., & Chen, H. (2017) · PubMed · Cited by 8
CRISPR/Cas9, a universal tool for genomic engineering
Smirnov, A. V., Yunusova, A., Lukyanchikova, V., & Баттулин, Н. Р. (2017) · Russian Journal of Genetics Applied Research · doi:10.1134/s2079059717040116 · Cited by 9
Genome Editing in Translational Medicine: An Inventory
Dobner, J., Ramachandran, H., & Rossi, A. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2708241 · Cited by 10
Wang, W., Huang, P., Dai, W., Tang, H., Qiu, Y., Chang, Y., Han, Z., Li, X., Du, L., Ye, X., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054416 · Cited by 8
Using Genome Engineering to Understand Huntington’s Disease
Bailus, B. J., Zhang, N., & Ellerby, L. (2017) · Research and perspectives in neurosciences · doi:10.1007/978-3-319-60192-2_9 · Cited by 8
Development of Toolboxes for Precision Genome/Epigenome Editing and Imaging of Epigenetics
Nomura, W. (2018) · The Chemical Record · doi:10.1002/tcr.201800036 · Cited by 8
Moving fast and breaking things: Incidence and repair of DNA damage within ribosomal DNA repeats
Blokhina, Y. P., & Buchwalter, A. L. (2020) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2020.111715 · Cited by 9
Cellular reprogramming by transcription factor engineering
Tsang, J. C. H., Gao, X., Lu, L., & Liu, P. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.07.001 · Cited by 8
Optimization Strategies for the CRISPR–Cas9 Genome-Editing SystemPreprint
Vejnar, C. E., Moreno-Mateos, M. A., Cifuentes, D., Bazzini, A., & Giráldez, A. J. (2016) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top090894 · Cited by 8
Germline Editing of Drosophila Using CRISPR-Cas9-Based Cytosine and Adenine Base Editors
Thakkar, N., Hejzlarova, A., Brabec, V., & Doležel, D. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0026 · Cited by 7
Melanin: Comprehensive Insights into Pathways and Sustainable Applications
Singh, R., Rahman, S., Abbas, S. A., Singh, A., Rahman, U., Sharma, M., Mir, N. R., Kapoor, N., & Kurian, N. K. (2025) · Current Pharmacology Reports · doi:10.1007/s40495-025-00417-y · Cited by 8
Ahmed, A., Molfetta, D. D., Iaconisi, G. N., Caponio, A., Singh, A., Bibi, A., Dolce, V., Palmieri, L., Coppola, V., & Fiermonte, G. (2026) · Cells · doi:10.3390/cells15010081 · Cited by 10
Genome im Fokus: Entwicklung und Anwendungen von CRISPR‐Cas9‐Bildgebungstechnologien
Knight, S. C., Tjian, R., & Doudna, J. A. (2017) · Angewandte Chemie · doi:10.1002/ange.201709201 · Cited by 7
CRISPR-mediated gene editing for the surgeon scientist
O’Brien, S. J., Ekman, M. B., Manek, S. E., & Galandiuk, S. (2019) · Surgery · doi:10.1016/j.surg.2019.01.030 · Cited by 7
Johnston, A. D., Abdulrazak, A., Sato, H., Maqbool, S. B., Suzuki, M., Greally, J. M., & Simões‐Pires, C. A. (2020) · The CRISPR Journal · doi:10.1089/crispr.2019.0077 · Cited by 7
Uncovering Inherited Cardiomyopathy With Human Induced Pluripotent Stem Cells
Jiang, X. D., Chen, Y., Liu, X., Ye, L., Yu, M., Shen, Z., Lei, W., & Hu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.672039 · Cited by 7
Molecular and functional characterization of the Drosophila melanogaster conserved smORFome
Bosch, J. A., Keith, N., Escobedo, F., Fisher, W. W., LaGraff, J. T., Rabasco, J. T., Wan, K. H., Weiszmann, R., Wu, Y., Hu, Y., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113311 · Cited by 7
Ping, N., Hara‐Kuge, S., Yagi, Y., Kazama, T., & Nakamura, T. (2024) · Scientific Reports · doi:10.1038/s41598-023-50776-z · Cited by 7
Contribution of Genetically Modified Crops in Agricultural Production: Success Stories
Bakhsh, A., Sırel, I. A., Kaya, R. B., Ataman, I. H., Tillaboeva, S., Dönmez, B. A., Yeşil, B., Yel, I., Tekinsoy, M., & Duru, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820780-2.00006-6 · Cited by 7
Roy, R. K., Debashree, I., Srivastava, S., Rishi, N., & Srivastava, A. (2021) · Current Bioinformatics · doi:10.2174/1574893616666210708150439 · Cited by 7
Understanding on CRISPR/Cas9 mediated cutting-edge approaches for cancer therapeutics
Bhattacharjee, R., Roy, L. D., & Choudhury, A. (2022) · Discover Oncology · doi:10.1007/s12672-022-00509-x · Cited by 7
Kharbikar, L. L., Konwarh, R., Chakraborty, M., Nandanwar, S. K., Marathe, A., Yele, Y., Ghosh, P. K., Mishra, N. S., & Singh, A. P. (2023) · Physiology and Molecular Biology of Plants · doi:10.1007/s12298-023-01397-3 · Cited by 8
Can Genome Engineering be used to Target Cancer-Associated Enhancers?
Grimmer, M., & Farnham, P. (2014) · Epigenomics · doi:10.2217/epi.14.30 · Cited by 7
Kirchner, M., & Schneider, S. (2015) · Angewandte Chemie · doi:10.1002/ange.201504741 · Cited by 7
Precise treatment of cystic fibrosis – current treatments and perspectives for using CRISPR
Colemeadow, J., Joyce, H., & Turcanu, V. (2016) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2016.1146077 · Cited by 8
Yang, M. G., & West, A. E. (2016) · Europe PMC (PubMed Central) · Cited by 7
GEMMs addressing Pax5 loss-of-function in childhood pB-ALL
Auer, F., Ingenhag, D., Bhatia, S., Enczmann, J., Cobaleda, C., Sánchez-Garcı́a, I., Borkhardt, A., & Hauer, J. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.11.009 · Cited by 6
Genome-wide CRISPR-Cas9 screen in E. coli identifies design rules for efficient targetingPreprint
Gutierrez, B., Wong-Ng, J., Cui, L., Bécavin, C., & Bikard, D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/308148 · Cited by 6
CRISPR/Cas systems for in situ imaging of intracellular nucleic acids: Concepts and applications
Chen, K., & Wang, Y. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28543 · Cited by 6
Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation
Takahashi, H., Sharma, H., & Carninci, P. (2019) · Journal of Visualized Experiments · doi:10.3791/58627 · Cited by 6
Wang, Y., Lecourieux, F., Zhang, R., Dai, Z., Lecourieux, D., Li, S., & Liang, Z. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.05.008 · Cited by 6
The genome editing revolution: A CRISPR-Cas TALE off-target story
Stella, S., & Montoya, G. (2015) · Inside the Cell · doi:10.1002/icl3.1038 · Cited by 6
Pelea, O., Mayes, S., Ferry, Q. R. V., Fulga, T. A., & Sauka‐Spengler, T. (2025) · eLife · doi:10.1101/2023.05.08.539738 · Cited by 6
Metadata
- Authors
- Wu, X., Scott, D. A., Kriz, A. J., Chiu, A. C., Hsu, P. D., Dadon, D. B., Cheng, A. W., Trevino, A. E., Konermann, S., Chen, S., Jaenisch, R., Zhang, F., & Sharp, P. A.
- Affiliations
- Koch Institute for Integrative Cancer Research At MIT (US)
- Broad Institute (US)
- Massachusetts Institute of Technology (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Zhang, Feng
- Sharp, Phillip A
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2014-04-20
- Volume
- 32
- Issue
- 7
- Pages
- 670-676
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4145672
- OpenAlex
- W1506494596
- Cited by
- 944
- References
- 47
- Citations by year
- 2026: 26 · 2025: 42 · 2024: 56 · 2023: 61 · 2022: 73 · 2021: 63 · 2020: 75 · 2019: 80 · 2018: 81 · 2017: 97 · 2016: 123 · 2015: 111 · 2014: 54
- FWCI
- 52.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- eScholarship (California Digital Library) (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Institute of Mental Health (DP1MH100706)
- National Cancer Institute (R01CA133404, P01CA042063, P30CA014051, P30-CA-14051, P01 CA 42063)
- National Institute of General Medical Sciences (R01GM034277, R01 GM34277, R37GM034277, T32GM007287)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK097768)
- National Center for Chronic Disease Prevention and Health Promotion (1DP1-MH100706)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37HD045022)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- Cas9, CRISPR/Cas9, dCas9, genome-wide binding sites, single guide RNA, Streptococcus pyogenes, mouse embryonic stem cells, off-target binding, seed sequence, protospacer adjacent motif, chromatin accessibility, DNA cleavage, target specificity
- MeSH terms
- Animals, Base Sequence, Binding Sites, Cells, Cultured, Deoxyribonuclease I, DNA-Binding Proteins, Models, Genetic, Molecular Sequence Data, Protein Binding, Genome, Mice, Embryonic Stem Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
